Sharepoint Solutions
PRODUCTS
-
120Water creates an easy, resident-friendly experience that takes the hassle out of compliance sampling for you. From easy-to-use kits and comprehensive collection support, to data collection and reporting, our team can lighten the load of your next monitoring period.
-
We provide science-first solutions for challenging molecules, specializing in particle engineering, bioavailability, and GMP manufacturing across Bend, OR; Clearwater, FL; and Gainesville, GA.
-
Optimize single-use solutions for cryopreservation by engaging in studies that focus on specific timepoints and conditions pertaining to therapy storage, containment/protection, and transportation.
-
Our proprietary GlobalReady model covers the entire drug development journey from robust EARLY PHASE clinical foundations with ClinicReady to seamless multi-regional Late phase expansion. All managed by the one award-winning CRO, saving time and costs and delivering rigorous globally accepted data.
-
When it comes to your fill-finish workflow, sterility and efficiency are key. Denest and renest with confidence! Our ready-to-use (RTU) denesting equipment is here to help you separate and reassemble your products with ease. Rest assured the Hull i-Dositecno Denesting Equipment is robust and efficient, so your sterile, clean, ready to fill (SCF) components are transported smoothly through your fill-finish workflow.
WHITE PAPERS AND CASE STUDIES
-
Are You Leveraging All Of Your Clinical Data?
To develop and execute a successful clinical strategy, trial sponsors must be able to rapidly acquire detailed data insights. Learn how you can better utilize your trial data and achieve greater insights.
-
Success Factors For Launching Products With Orphan Drug Designation
Orphan drug designation offers a number of financial incentives to pharmaceutical companies. Learn more about the potential hurdles of orphan drug development and the opportunities to maximize your success.
-
Eliminating The Guesswork From Critical Decision Making
By leveraging a unified platform, see how this sponsor was able to overcome the logistical complexities of patient randomization, streamlining, and condensing processes.
-
Advancing Rare Disease Clinical Trials With Point-Of-Need Eye Assessments
During the COVID-19 pandemic, Applied Genetic Technologies Corporation (AGTC) faced significant hurdles in enrolling participants due to travel restrictions and site limitations.
-
Earning RMAT Designation - What Developers Need To Know
Explore a high-level overview of the Regenerative Medicine Advanced Therapy designation and how to ensure success and accelerate advanced therapy products toward commercialization.
-
Patient-Focused Data Capture For Cancer Research
In a field where innovation is constant and patient experience is pivotal, oncology demands eCOA solutions designed to balance scientific rigor with human realities.
-
The Benefits Of End-To-End Formulation And Fill/Finish Of Biologics
Proper formulation development has a huge impact on whether a technology transfer to clinical phase fill/finish is successful. Review the challenges of transitioning a promising drug candidate.
-
The Foundation Of Peak Performance
In this case study, read about an underdrain system that continues to operate as expected after 16 years of operation and appears to be in perfect condition.
-
Accelerated Peptide Drug Development And Clinical Strategies
Review how an integrated platform approach and innovative filtration strategies helped bring a novel therapeutic to Phase 1 clinical trials with reduced time and costs.
-
Retrofit Of A Brand New Pump Station
Due to clogging problems, a pump station was experiencing reduced pump performance, longer pump run times, significant vibration issues, and the need to be physically unclogged.
-
AqueoUS Vets Named A Manufacturing Partner For A Southern CA Water Treatment Facility
In August 2018, Aqueous Vets was selected over existing industry incumbents to supply the Granular Activated Carbon Systems (GACS) for a Southern California Water Treatment Plant.
-
Regulatory Considerations For Excipients Used In Lipid Nanoparticles
Review the regulatory classification of LNPs, liposomes, and novel excipients as well as specific requirements outlined in regulatory guidance documents and strategies to navigate emerging challenges.
NEWS
-
Biden-Harris Administration Announces $7.5B In Available Financing For Water Infrastructure Projects9/6/2024
Today, September 6, the U.S. Environmental Protection Agency announced the availability of $7.5B of Water Infrastructure Finance and Innovation Act (WIFIA) funding.
-
EPA Announces $5.8 Billion For Drinking Water, Wastewater And Stormwater Infrastructure Upgrades2/20/2024
As part of the fourth Investing in America tour, Vice President Kamala Harris and U.S. Environmental Protection Agency Administrator Michael S. Regan announced over $5.8B from President Biden’s Investing in America agenda for states, Tribes, and territories to invest in drinking water and clean water infrastructure upgrades.
-
Biden-Harris Administration Announces $94M WIFIA Loan To Upgrade Wastewater Infrastructure In New Lenox, IL3/11/2024
Today, the U.S. Environmental Protection Agency (EPA) announced a $94M Water Infrastructure Finance and Innovation Act (WIFIA) loan to the Village of New Lenox in northeastern Illinois.
-
EPA Announces $188.3M WIFIA Loan To Upgrade And Expand Water Services In Central Florida8/13/2024
Today, at an event in Kissimmee, Fla. with U.S. Representative Darren Soto, U.S. Environmental Protection Agency Deputy Assistant Administrator for Water Mae Wu announced a $188.3M Water Infrastructure Finance and Innovation Act (WIFIA) loan to the Toho Water Authority.
-
Avance Clinical Expands Specialist CNS, Cardiometabolic, And Rare Diseases CRO Services In Europe With Julius Clinical5/28/2024
Avance Clinical, the award-winning Australian and North American market-leading CRO for biotechs has signed a Memorandum of Understanding (MOU) with Julius Clinical, a leading CNS, cardiometabolic, and rare diseases specialist CRO with extensive site relationships in the region.